Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

CrowdStrike shares slide as traders take profits after a strong run, with valuation and AI-competition worries still in focus

None

CrowdStrike Holdings (CRWD) is down 4.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The move looks most consistent with near-term profit-taking after a multi-day rally, with investors still sensitive to valuation and ongoing debate about how fast-moving AI tooling could reshape parts of the cybersecurity software landscape. There was no single, clearly dominant company-specific headline tied to the drop that circulated broadly during the session.

Details:

  • CrowdStrike had recently logged a notable multi-day winning streak, which can set up a pullback as short-term traders lock in gains.
  • The company announced an expanded share repurchase authorization earlier in April, which can support sentiment but also highlights management’s view that the stock’s price has disconnected from fundamentals.
  • Earlier April trading saw heightened investor focus on whether new AI models/agents could change security workflows and compress software multiples, a narrative that has pressured several growth software names.
  • With the stock still priced at a premium versus many software peers, even modest shifts in risk appetite can translate into outsized daily moves.
  • Sources:

    CrowdStrike Investor Relations, Trefis, StockStory (via Wedbush site)

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $CRWD Insider Trading Activity

    CRWD Insider Trades

    $CRWD insiders have traded $CRWD stock on the open market 154 times in the past 6 months. Of those trades, 0 have been purchases and 154 have been sales.

    Here’s a breakdown of recent trading of $CRWD stock by insiders over the last 6 months:

    • GEORGE KURTZ (PRESIDENT AND CEO) has made 0 purchases and 80 sales selling 97,070 shares for an estimated $42,451,900.
    • BURT W. PODBERE (CHIEF FINANCIAL OFFICER) has made 0 purchases and 19 sales selling 37,892 shares for an estimated $16,680,477.
    • MICHAEL SENTONAS (PRESIDENT) has made 0 purchases and 2 sales selling 30,828 shares for an estimated $13,459,757.
    • SAMEER K GANDHI has made 0 purchases and 31 sales selling 12,473 shares for an estimated $6,698,255.
    • DENIS OLEARY has made 0 purchases and 4 sales selling 7,750 shares for an estimated $3,994,628.
    • ANURAG SAHA (CHIEF ACCOUNTING OFFICER) has made 0 purchases and 4 sales selling 6,661 shares for an estimated $2,954,138.
    • JOHANNA FLOWER has made 0 purchases and 14 sales selling 3,000 shares for an estimated $1,385,820.

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    $CRWD Hedge Fund Activity

    We have seen 1,089 institutional investors add shares of $CRWD stock to their portfolio, and 819 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    $CRWD Congressional Stock Trading

    Members of Congress have traded $CRWD stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

    Here’s a breakdown of recent trading of $CRWD stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

    $CRWD Analyst Ratings

    Wall Street analysts have issued reports on $CRWD in the last several months. We have seen 13 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Citigroup issued a "Buy" rating on 01/13/2026
    • BTIG issued a "Buy" rating on 01/13/2026
    • Freedom Capital Markets issued a "Buy" rating on 12/11/2025
    • Goldman Sachs issued a "Buy" rating on 12/04/2025
    • JP Morgan issued a "Overweight" rating on 12/03/2025
    • Rosenblatt issued a "Buy" rating on 12/03/2025
    • BMO Capital issued a "Outperform" rating on 12/03/2025

    To track analyst ratings and price targets for $CRWD, check out Quiver Quantitative's $CRWD forecast page.

    $CRWD Price Targets

    Multiple analysts have issued price targets for $CRWD recently. We have seen 36 analysts offer price targets for $CRWD in the last 6 months, with a median target of $505.0.

    Here are some recent targets:

    • Eric Heath from Keybanc set a target price of $525.0 on 04/21/2026
    • Joshua Tilton from Wolfe Research set a target price of $450.0 on 03/30/2026
    • Matthew Hedberg from RBC Capital set a target price of $550.0 on 03/17/2026
    • Keith Weiss from Morgan Stanley set a target price of $510.0 on 03/10/2026
    • Fatima Boolani from Citigroup set a target price of $525.0 on 03/05/2026
    • Peter Weed from Bernstein set a target price of $368.0 on 03/04/2026
    • Mike Cikos from Needham set a target price of $475.0 on 03/04/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles